RP916

N/A

Report date: 2024/11/27 10:30:40
NME

Base Information

Drug NameRP916
Drug Alias NameRP916RP-916
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionVirus DNA polymerase inhibitors
TargetsVirus DNA polymerase
Therapy Area/IndicationsMonkeypox
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesRisen(Shanghai) Pharma Tech Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesRisen(Shanghai) Pharma Tech Co Ltd
Inactive CompaniesN/A
Active IndicationsMonkeypox
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A